title: Anxiety and depression.
authors.affiliation: Thomson Scientific, Middlesex House, London, UK. steven.tear@thomson.com
authors.forename: Steven
authors.initials: S
authors.lastname: Tear
authors.forename: Saloni
authors.initials: S
authors.lastname: Shah
mesh_terms: D000374:Aggression / Q000187:drug effects; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006930:Hyperalgesia / Q000188:drug therapy; D007211:Indoles / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D017465:Receptors, Opioid, delta / Q000819:agonists; D013844:Thiazoles / Q000627:therapeutic use
chemical_list: C456029:1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide; C451725:4-(2-chloro-4-methoxy-5-methylphenyl)-N(2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl)-5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D007211:Indoles; D011759:Pyrrolidines; D017465:Receptors, Opioid, delta; D013844:Thiazoles